Related Experiment Video
Updated: Jan 26, 2026

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
Published on: April 15, 2016
[Treatment of the advanced HCC: A second revolution by using immunotherapy]
Laetitia Fartoux1, Olivier Rosmorduc1
1Service d'Hépato-Gastro-Entérologie, Hôpital de la Pitié-Salpêtrière, 83 boulevard de l'Hôpital, 75013, Paris, France.
Abstract:
The treatment of advanced hepatocellular carcinoma has long been hopeless due to an absence of effective molecules and an underlying cirrhosis, compromising tolerance to conventional chemotherapy. A targeted anti-angiogenic therapy, sorafenib, has been the only option for a decade before new oral molecules have been finally validated. Immunotherapy, intended to correct the immunosuppressive context frequently associated with this tumor, has shown very promising results and could profoundly challenge the therapeutic algorithm of advanced hepatocellular carcinoma.
Insights
Advanced hepatocellular carcinoma treatment was limited until new oral drugs and immunotherapy emerged. Immunotherapy shows promise for correcting the tumor
Area of Science:
- Hepatobiliary oncology
- Medical oncology
- Cancer immunotherapy
Background:
- Advanced hepatocellular carcinoma (HCC) treatment options were historically limited.
- Cirrhosis often compromises patient tolerance to conventional chemotherapy.
- Sorafenib, a targeted anti-angiogenic therapy, was the sole option for a decade.
Purpose of the Study:
- To review the evolution of treatment strategies for advanced hepatocellular carcinoma.
- To highlight the impact of newly validated oral molecules.
- To discuss the emerging role of immunotherapy in advanced HCC.
Main Methods:
- Review of clinical trial data and therapeutic guidelines.
- Analysis of treatment outcomes for advanced HCC.
- Evaluation of the potential of novel therapeutic agents.
Main Results:
- New oral molecules have been validated, expanding treatment options.
- Immunotherapy demonstrates significant promise by addressing the tumor's immunosuppressive microenvironment.
- These advancements challenge the existing therapeutic algorithm for advanced HCC.
Conclusions:
- The therapeutic landscape for advanced HCC is rapidly evolving.
- Immunotherapy represents a paradigm shift, offering new hope for patients.
- Further research is warranted to integrate these novel therapies effectively.
Related Concept Videos
Centroid for the Paraboloid of Revolution
The centroid for the paraboloid of revolution is the point where all the mass of the paraboloid is concentrated. This centroid is important for engineering applications, as it determines how forces are...
Tumor Immunotherapy
Extraction: Advanced Methods
Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
Sample Preparation for Analysis: Advanced Techniques
Acid digestion with strong acids is commonly used to dissolve inorganic materials that are insoluble (do not dissolve) in water. This method can be useful for...
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques

